Cyclic Pamidronate Infusion for Neonatal-onset Osteogenesis Imperfecta
Patients with severe osteogenesis imperfecta (OI; MIM number 259420) suffer from low bone mass, fractures, and bone pain since birth, and have poor prognosis. This study assessed the outcome of patients with severe OI who were treated with cyclic pamidronate prior to the age of 1 year. Methods: The...
Saved in:
Main Authors: | Chia-Hsuan Lin (Author), Yin-Hsiu Chien (Author), Shinn-Forng Peng (Author), Wen-Yu Tsai (Author), Yi-Ching Tung (Author), Cheng-Ting Lee (Author), Chun-Ching Chien (Author), Wuh-Liang Hwu (Author), Ni-Chung Lee (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2014-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapy with pamidronate in children with osteogenesis imperfecta
by: Marginean O, et al.
Published: (2017) -
Intravenous Pamidronate Therapy in Taiwanese Patients with Osteogenesis Imperfecta
by: Hsiang-Yu Lin, et al.
Published: (2008) -
Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta
by: Yunha Choi, et al.
Published: (2022) -
Pectus excavatum in osteogenesis imperfecta type I treated with Nuss procedure after pamidronate therapy
by: Nelimar Cruz Centeno, et al.
Published: (2021) -
Treatment of osteogenesis imperfecta with intravenous pamidronate in pediatric patients: comparison between a single-day infusion twice a year protocol with other regimens described in the literature
by: Ricart S, et al.
Published: (2008)